Ambrx Links Its ADC Technology To Japan’s Astellas In Oncology Deal

The San Diego biotech has landed another large pharma partner for its antibody-drug conjugation technology as the space continues to attract interest.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Platform Technologies

More from Advanced Technologies